Abstract:Abstract Glioma is the most common primary tumour in central nervous system, characterized by high invasiveness, a high recurrence rate and extremely poor prognosis. Machine learning based on cancer functional state helps to combine multi‐omics methods to screen for key gene, such as CENPA, that influences the phenotype of glioma and patients' prognosis. Based on 14 CFS, glioma was divided into three subtypes. Bioinformatics and machine learning methods were utilized to develop an enhanced prognostic prediction signature based on three subtypes. We selected CENPA as a hub biomarker and conducted in vitro experiments such as IHC, western blot, Coip, transwell, cck8, flow cytometry, scratch assay, qPCR, AlphaFold, MOE and in vivo experiments. We identified three subtypes of glioma based on the 14 CFS. The C subtype exhibits poor clinical outcomes, increased carbohydrate and nucleotide metabolism, high infiltration of immune cells, high CNV and tumour mutation burden ( p < 0.05). The differential expression of gene between three subtypes were used to construct a novel signature with improved performance in prognostic prediction via machine learning. CENPA was selected as the hub gene, in vitro experiments such as ihc, western blot and qPCR showed that CENPA had high expression in tissues and cell lines ( p < 0.05). The scratch assay, edu, cck8, flow cytometry and transwell after CENPA knockdown or overexpression had significant effects on the functions of glioma. Meanwhile, CENPA was regulated by EZH2 and influenced downstream wnt pathway, affecting phosphorylation of two sites, Ser675 and Ser552, on β‐catenin. The effect of CENPA knockdown was reversed by drug CHIR‐99021. Animal experiments indicated that the tumour volume of control and overexpression group increased faster, especially the overexpression group, which was significantly faster ( p < 0.001). Machine learning based on CFS is beneficial for the selection of key genes and disease assessment. In glioma, CENPA is positively correlated with WHO grading at both the gene and protein levels, and high CENPA affects patients' poor prognosis. Regulating CENPA can affect functions of glioma, and these phenomena may act through the EZH2/CENPA/β‐catenin signalling axis. CENPA knockdown can be reversed by the drug CHIR‐99021. CENPA may become one of the therapeutic targets in glioma.

CENPA facilitates glioma stem cell stemness and suppress ferroptosis to accelerate glioblastoma multiforme progression by promoting GBP2 transcription

Hmga2 Sustains Self-Renewal and Invasiveness of Glioma-Initiating Cells

CENPA Acts As a Prognostic Factor That Relates to Immune Infiltrates in Gliomas

Exploration of the biological mechanisms of CENPA as an oncogene in glioma: Screening based on cancer functional status

Knockdown of CENPF Induces Cell Cycle Arrest and Inhibits Epithelial‑mesenchymal Transition Progression in Glioma.

Nonstructural Maintenance of Chromatin Condensin I Complex Subunit G Promotes the Progression of Glioblastoma by Facilitating Poly (Adp-Ribose) Polymerase 1-Mediated E2F1 Transactivation

CENPN Acts as a Novel Biomarker that Correlates With the Malignant Phenotypes of Glioma Cells

GBP2 facilitates the progression of glioma via regulation of KIF22/EGFR signaling

GBP2 enhances glioblastoma invasion through Stat3/fibronectin pathway

Integrated Analysis Reveals Prognostic Value and Mesenchymal Identity Suppression by Glycoprotein M6B in Glioma.

HMGN2 Accelerates the Proliferation and Cell Cycle Progression of Glioblastoma by Regulating CDC20 Expression

Overexpression of GBP1 Predicts Poor Prognosis and Promotes Tumor Growth in Human Glioblastoma Multiforme.

CENPO Expression Regulates Gastric Cancer Cell Proliferation and is Associated with Poor Patient Prognosis

Epco-27. Chromatin Remodeling Reprograms The Transcription Network In Glioblastoma

CPEB2 m6A Methylation Regulates BTB Permeability via Affecting Splicing Factor SRSF5 Stability

EGFR‐ERK pathway regulates CSN6 to contribute to PD‐L1 expression in glioblastoma

Single-Cell and Bulk RNA Sequencing Analysis Reveals CENPA As a Potential Biomarker and Therapeutic Target in Cancers

Loss of COPZ1 induces NCOA4 mediated autophagy and ferroptosis in glioblastoma cell lines

Intracellular C5aR1 inhibits ferroptosis in glioblastoma through METTL3-dependent m6A methylation of GPX4

Up-regulation of LPCAT1 is correlated with poor prognosis and promotes tumor progression in glioblastoma

Author Correction: Apolipoprotein C1 Promotes Glioblastoma Tumorigenesis by Reducing KEAP1/NRF2 and CBS-regulated Ferroptosis